Received Jan 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | 3052735 | IM |
fatigue; headache; myalgia; chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), HEADACHE (headache), MYALGIA (myalgia) and CHILLS (chills) in a 78-year-old male patient who received mRNA-1283 (MNEXSPIKE PFS) (batch no. 3052735) for COVID-19 prophylaxis. The suspect product included Pre-filled Syringe injection (batch no. 3052735) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Dec-2025, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) .2 milliliter. On an unknown date, the patient started Pre-filled Syringe (unknown route) at an unspecified dose. On 28-Dec-2025, the patient experienced FATIGUE (fatigue), HEADACHE (headache), MYALGIA (myalgia) and CHILLS (chills). At the time of the report, FATIGUE (fatigue), HEADACHE (headache), MYALGIA (myalgia) and CHILLS (chills) had not resolved. The action taken with mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) was unknown. Concomitant medication was not provided. It was reported that the patient had experienced symptoms within 4 hours of vaccination. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported. .